SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-19-020321
Filing Date
2019-10-15
Accepted
2019-10-15 08:40:34
Documents
2
Group Members
ALPHA BIOLABS, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.3 TO SCHEDULE 13D sc13d1019a3alpha_oncosec.htm SC 13D/A 55742
2 BOOKS AND RECORDS DEMAND DATED OCTOBER 10, 2019 sc13d1019a3ex99-1_oncosec.htm EX-99.1 35524
  Complete submission text file 0001213900-19-020321.txt   92800
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Subject) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-86770 | Film No.: 191149343
SIC: 2834 Pharmaceutical Preparations

Mailing Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016
Business Address GANGNAM-GU APGUJEONG-RO 62-GIL 17-10 SEOUL M5 06016 011-8225178841
Alpha Holdings, Inc. (Filed by) CIK: 0001755469 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A